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Abstract
Background: To compare the changes in anterior and posterior corneal elevations after combined transepithelial
photorefractive keratectomy (PRK) and accelerated corneal collagen cross-linking (CXL) and after PRK.
Methods: Medical records of 82 eyes of 44 patients undergoing either combined transepithelial PRK and CXL
(PRK-CXL group) or transepithelial PRK (PRK group) were examined retrospectively. Changes in anterior and
posterior corneal elevations were calculated by fitting an 8.0-mm diameter best-fit sphere and best-fit toric ellipsoid
(BFTE) to the corneal shape with a fixed eccentricity of 0.4 using Scheimpflug tomography (Pentacam HR; Oculus
Optikgeräte GmbH, Wetzlar, Germany) preoperatively and 6 months postoperatively.
Results: In anterior corneal elevation, both groups demonstrated a similar trend of a forward displacement of
peripheral anterior corneal surface and a backward displacement of central anterior corneal surface. In posterior
corneal elevation, a forward displacement of peripheral posterior corneal surface was induced in both groups,
along with a backward displacement of central posterior corneal surface, regardless of the calculation method. The
magnitudes of displacement of peripheral and central posterior corneal surfaces were significantly smaller in the
PRK-CXL group than in the PRK group. Moreover, the PRK-CXL group showed a backward displacement of posterior
corneal surface at maximum corneal elevations when the BFTE was used as the reference surface.
Conclusions: Transepithelial PRK combined with prophylactic CXL significantly reduced the magnitudes of
displacement of peripheral and central posterior corneal surfaces, with the radius of the BFTE was set to 8.0-mm on
the Scheimpflug tomography system.
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Background
Elevation of the posterior corneal surface can occur after
myopic photorefractive keratectomy (PRK) and laser
in-situ keratomileusis (LASIK) [1–3]. Early studies
using scanning-slit topography (Orbscan; Bausch &
Lomb, Rochester, NY, USA) showed forward displace-
ment of the posterior corneal surface, whereas later
studies using the Scheimpflug tomography system
(Pentacam HR; Oculus Optikgeräte GmbH, Wetzlar,
Germany) showed minimal or no changes in posterior
corneal elevations [1, 3–6]. In addition, differences in
methods of measurement of posterior corneal eleva-
tion could considerably affect the results [6–10]. Ac-
curate and reliable measurement of posterior corneal
elevations is crucial because posterior corneal eleva-
tion after myopic laser refractive surgery could indi-
cate postoperative ectasia.
Collagen cross-linking (CXL) is a recently developed
surgical procedure whereby riboflavin sensitization with
ultraviolet-A (UVA) radiation induces stromal cross-
linking [11]. This procedure alters corneal biomechanics
and increases mechanical rigidity (i.e., strengthens the
corneal tissue) in porcine and human corneas, resulting
in significant increases in the stiffness of the anterior
corneal stroma [12]. Clinically, patients with keratoco-
nus, ectasia following photorefractive surgery, and even
corneal infections and chemical burns can benefit from
CXL [13, 14]. A recently introduced accelerated CXL
protocol consisting of higher-intensity light applied for a
shorter period of time can be applied in various clinical
settings [15]. The outcomes of this protocol are compar-
able to those of conventional CXL, with no evidence of
endothelial cell density changes [16].
Application of prophylactic CXL concurrently with my-
opic LASIK surgery may increase corneal stabilization
following photorefractive surgery. Several studies have
evaluated the safety and efficacy of combined LASIK and
CXL, reporting no signs of ectasia or significant regression
during the follow-up period [17, 18]. Furthermore, con-
current CXL and myopic LASIK surgery improves refract-
ive and keratometric stability to a greater degree than
does standard LASIK alone [19].
The Scheimpflug tomography system evaluates corneal
indices by providing multiple corneal descriptors. Add-
itionally, it allows measurements of local elevation
points by fitting the corneal shape to a best-fit sphere
(BFS) or best-fit toric ellipsoid (BFTE) reference surface.
Scheimpflug tomography reveals posterior corneal eleva-
tion values by analyzing the posterior corneal surface
directly [4, 5, 8]. Moreover, posterior corneal elevation
measurements obtained with Scheimpflug tomography
have relatively acceptable reproducibility and repeatabil-
ity in both normal eyes and eyes with keratoconus and a
history of CXL [10, 20, 21].
Because of the positive effects of concurrent prophy-
lactic CXL, we hypothesized that combined application
of prophylactic CXL and transepithelial PRK would have
a positive effect on refractive outcomes and posterior
corneal elevations. To the best of our knowledge, no
studies have evaluated the effects of combined transe-
pithelial PRK and accelerated corneal CXL on changes
in anterior and posterior corneal elevations. Therefore,
we aimed to investigate changes in anterior and poster-
ior corneal elevations using Scheimpflug tomography
after combined transepithelial PRK and accelerated cor-
neal CXL and after transepithelial PRK alone.
Methods
We performed this retrospective, comparative observa-
tional case series with the approval of the Institutional
Review Board of Yonsei University College of Medicine
(Seoul, South Korea). All study conduct adhered to the
tenets of the Declaration of Helsinki and followed good
clinical practices. All patients provided written informed
consent for their medical information to be included in
study analyses. Patients included in the study were older
than 20 years and underwent either combined transe-
pithelial PRK and accelerated corneal CXL (PRK-CXL
group) or transepithelial PRK alone (PRK group) in a
standardized fashion by the same surgeon between
August 2014 and March 2015. We excluded patients
with previous ocular or intraocular surgery, ocular ab-
normalities other than myopia or myopic astigmatism
with a corrected distance visual acuity (CDVA) of 1.00
(20/20 Snellen) or better in both eyes, central corneal
thickness (CCT) of less than 460 μm, corneal endothelial
cell density of less than 2000 cells/mm2, cataract, ocular
inflammation, or infection. We also excluded patients
with signs of keratoconus on Scheimpflug tomography
(displacement of the corneal apex, decrease in thinnest-
point pachymetry, and asymmetric topographic pattern).
According to our study protocol, we used combined
transepithelial PRK and accelerated corneal CXL if a pa-
tient had any of the following preoperative measure-
ments: CCT less than 500 μm regardless of the amount
of ablation or predicted residual postoperative stromal
thickness less than 300 μm. We retrospectively reviewed
the medical records of 44 patients (82 eyes) meeting the
inclusion and exclusion criteria.
Examinations and measurements
Before and 6 months after surgery, all patients under-
went complete ophthalmic examinations that included
examinations for uncorrected distance visual acuity
(UDVA) and CDVA, manifest refraction, slit-lamp examin-
ation (Haag-Streit, Gartenstadtstrasse, Köniz, Switzerland),
intraocular pressure measurement (noncontact tonometer;
NT-530, NCT Nidek Co., Ltd., Aichi, Japan), and fundus
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examination. Keratometric values and CCT were measured
using autokeratometry (ARK-530A; Nidek Co., Ltd.) and
ultrasound pachymetry (UP-1000; Nidek Co., Ltd.),
respectively.
We measured the anterior and posterior corneal eleva-
tions without dilation preoperatively and at 6 months
postoperatively using Scheimpflug tomography (Pentacam
HR). We analyzed anterior and posterior corneal eleva-
tions at the peripheral (including 6 mm and 4 mm) and
central (including 2 mm and center) zones by using an
8.0-mm-diameter area to calculate the BFS and BFTE
fixed to the corneal apex defined by Scheimpflug tomog-
raphy with a fixed eccentricity of 0.4. We also analyzed
anterior and posterior maximum corneal elevations over
the entire cornea. We determined changes in corneal ele-
vations by subtracting the preoperative elevation from the
postoperative elevation. The same reference surfaces were
used to compare preoperative and postoperative states for
direct comparison purposes. Forward protrusion of the
anterior and posterior corneal surface resulted in a
positive number. The same investigator performed all
measurements, and we analyzed only high-quality
measurements (quality score ≥90 %). The investigator
performed each measurement 3 times, and we ana-
lyzed the average of the 3 measurements.
Surgical technique
Transepithelial PRK was performed using an excimer
laser (Amaris 1050 Excimer Laser platform; Schwind
eye-tech-solutions GmbH and Co KG, Kleinostheim,
Germany). After excimer laser ablation was complete,
patients in the PRK-CXL group were treated with 0.1 %
riboflavin with hydroxypropyl methylcellulose (Vibex
Rapid; Avedro Inc, Waltham, MA, USA) placed on the
corneal surface and carefully spread with an irrigating
cannula for 120 s. After 120 s of soaking time, the cor-
neal surface was rinsed thoroughly with 60 cm3 of
chilled balanced salt solution (BSS). A UVA beam (wave-
length, 365 nm) 9.0 mm in diameter was applied to the
cornea in a pulsatile fashion (1:1) in a uniform circular
pattern by the KXL system (Avedro Inc). The UVA expos-
ure was performed for 180 s at a power of 30 mW/cm2
(total dose, 2.7 J/cm2). Mitomycin 0.02 % was applied to
all corneas for 20 s after cessation of UVA irradiation,
followed by thorough rinsing with chilled BSS.
Postoperatively, 1 drop of topical levofloxacin 0.5 %
(Cravit; Santen Pharmaceutical, Osaka, Japan) was in-
stilled at the surgical site, and a bandage contact lens
(Acuvue Oasys; Johnson & Johnson Vision Care, Inc,
Jacksonville, FL, USA) was placed on the cornea for both
groups. Following surgery, topical levofloxacin 0.5 % and
fluorometholone 0.1 % (Flumetholon; Santen Pharma-
ceutical) were applied 4 times per day for 1 month. The
dosage was tapered over 3 months.
Statistical analysis
Statistical analysis was performed using SAS software
(version 9.2; SAS Institute, Inc, Cary, NC, USA). Results
are expressed as mean ± standard deviation. We used the
Kolmogorov–Smirnov test to confirm data normality.
To statistically compare data from eyes that underwent
combined transepithelial PRK and CXL or transepithelial
PRK alone, we used independent t tests for continuous
variables and χ2 tests for categorical variables. We per-
formed paired t tests to evaluate the differences between
preoperative and 6-month postoperative corneal eleva-
tion values in each group. We used independent t tests
to compare changes in corneal elevation values between
eyes that underwent combined transepithelial PRK and
CXL and those that underwent transepithelial PRK
alone. We used Pearson correlation analysis to evaluate
the correlation between changes in posterior corneal
elevation and preoperative parameters, including age,
optical zone diameter, total ablation zone diameter, abla-
tion depth, mean keratometric values, CCT, and spher-
ical equivalent, in the PRK-CXL and PRK groups. In
addition, we performed multiple regression analysis to
evaluate the impact of preoperative parameters on
changes in corneal elevation in the PRK-CXL and PRK
groups. A P value of less than 0.05 was considered statis-
tically significant.
Result
This study included 82 eyes of 44 patients (18 women,
26 men). The mean patient age was 25.4 ± 5.1 years
(range, 20 to 38 years). The analysis revealed that there
was no significant difference between the PRK-CXL and
PRK groups in age, spherical or cylindrical refractive
error, spherical equivalent refraction, keratometric values,
optical zone, total ablation zone, or ablation depth, except
for CCT (Table 1).
In the PRK-CXL group, the mean UDVA was
0.04 ± 0.03 preoperatively and 1.22 ± 0.25 at 6 months
postoperatively (P < 0.001). The mean manifest refrac-
tion spherical equivalent (MRSE) was −6.18 ± 1.28 diop-
ters (D) preoperatively and 0.03 ± 0.53D at 6 months
postoperatively (P < 0.001). In the PRK group, mean
UDVA was 0.04 ± 0.02 preoperatively and 1.27 ± 0.22 at
6 months postoperatively (P < 0.001). The mean MRSE
was −6.42 ± 1.17D preoperatively and −0.04 ± 0.65D at
6 months postoperatively (P < 0.001).
Table 2 demonstrates the results of the comparison of
anterior corneal elevation values between the PRK-CXL
and PRK groups by fitting the corneal shape to the BFS
or BFTE reference surface. Both groups showed signifi-
cant forward displacement of the peripheral anterior
corneal surface (including the 6-mm and 4-mm zones)
with both the BFS and BFTE (P < 0.001). In cases with cen-
tral anterior corneal elevations, backward displacements of
Lee et al. BMC Ophthalmology  (2016) 16:139 Page 3 of 9
the central anterior corneal surface (including the 2-mm
zone and center) were statistically significant in both
groups with both the BFS and BFTE (P < 0.001).
Table 3 demonstrates the results of the comparison
between the two groups in posterior corneal elevation
values by fitting the corneal shape to the BFS or BFTE
reference surface. Both groups showed significant for-
ward displacement of the peripheral posterior corneal
surface with both the BFS and BFTE. However, there
were statistically significant differences in posterior
corneal elevation changes between the two groups
(P = 0.001 for the BFS and P = 0.010 for the BFTE),
although the magnitudes were small (<2 μm; Fig. 1).
Both groups showed significant backward displace-
ment of the central posterior corneal surface with both
the BFS and BFTE (P < 0.001; Table 3). However, com-
pared with the PRK group, the PRK-CXL group showed
a significantly small magnitude of backward displace-
ment of the central posterior corneal surface when cal-
culated with the BFTE (P = 0.049; Fig. 1).
Table 1 Characteristics of eyes that underwent combined transepithelial photorefractive keratectomy and accelerated corneal
collagen cross-linking and transepithelial photorefractive keratectomy alone
Characteristics PRK-CXL group (n = 40) PRK group (n = 42) P
Age, years old 25.8 ± 5.7 (20 to 38) 25.1 ± 4.6 (20 to 36) .542
Sex (% women) 43 % 38 % .717
Refractive errors (D)
Spherical –5.46 ± 1.20 (–7.50 to–3.00) –5.78 ± 1.22 (–8.00 to–2.62) .233
Cylindrical –1.44 ± 0.73 (–2.62 to 0) –1.27 ± 0.83 (–3.25 to 0) .321
Spherical equivalent –6.18 ± 1.28 (–8.12 to–3.50) –6.42 ± 1.17 (–8.75 to–3.81) .385
Keratometric value
Flat K 42.3 ± 1.1 (40.3 to 44.3) 42.6 ± 1.3 (39.3 to 44.8) .242
Steep K 44.1 ± 1.2 (41.0 to 46.0) 44.2 ± 1.5 (41.0 to 47.0) .748
Preoperative CDVA 1.00 ± 0.02 (1.00 to 1.00) 1.01 ± 0.04 (1.00 to 1.00) .160
Preoperative UDVA 0.04 ± 0.03 (0.01 to 0.15) 0.04 ± 0.02 (0.02 to 0.10) .755
Optical zone (mm) 6.36 ± 0.23 (5.80 to 6.90) 6.32 ± 0.16 (6.00 to 6.70) .280
Total ablation zone (mm) 8.10 ± 0.28 (7.45 to 8.64) 8.17 ± 0.36 (7.66 to 9.00) .335
Ablation depth (μM) 101.54 ± 19.65 (54.13 to 128.68) 97.71 ± 20.56 (48.54 to 146.94) .391
CCT (μM) 510.2 ± 32.9 (460.0 to 590.0) 537.8 ± 23.2 (501.0 to 610.0) <.001
Results are expressed as means ± standard deviation (range)
PRK-CXL = Combined transepithelial photorefractive keratectomy and accelerated corneal collagen cross-linking; PRK = transepithelial photorefractive keratectomy;
D = diopters; K = keratometric value; CDVA = corrected distance visual acuity; UDVA = uncorrected distance visual acuity; CCT = central corneal thickness
Table 2 Comparison of anterior corneal elevation values by fitting the corneal shape to a best-fit sphere or best-fit toric ellipsoid
reference surface between eyes that underwent combined transepithelial photorefractive keratectomy and accelerated corneal
collagen cross-linking and transepithelial photorefractive keratectomy alone
PRK-CXL group (n = 40) PRK group (n = 42) Pb
Pre 6 mon Δ Pa Pre 6 mon Δ Pa
Peripheral zone
Ant. elevation (μm, BFS) –3.59±1.04 9.82±6.76 13.41±6.42 <.001 –3.35±1.17 11.55±5.21 14.90±4.83 <.001 .123
Ant. elevation (μm, BFTE) –0.27±1.17 12.27±5.32 12.54±6.42 <.001 –0.20±1.13 11.78±5.33 11.98±5.07 <.001 .524
Central zone
Ant. elevation (μm, BFS) 4.38±1.62 –9.19±7.33 –13.57±7.26 <.001 4.08±1.65 –10.36±5.95 –14.44±5.87 <.001 .442
Ant. elevation (μm, BFTE) 0.78±1.75 –10.85±6.76 –11.63±6.60 <.001 0.79±1.52 –10.86±6.64 –11.65±6.57 <.001 .988
Max. elevation
Ant. elevation (μm, BFS) 13.29±5.39 20.23±6.74 6.94±7.23 <.001 9.36±4.72 17.34±5.12 7.98±5.05 <.001 .320
Ant. elevation (μm, BFTE) 2.78±4.13 13.73±4.05 10.95±5.54 <.001 2.43±1.27 12.79±4.03 10.36±4.22 <.001 .500
PRK-CXL = Combined transepithelial photorefractive keratectomy and accelerated corneal collagen cross-linking; PRK = transepithelial photorefractive keratectomy;
Δ = change; Peripheral zone =measurements of 6-mm and 4-mm zone; BFS = best-fit sphere; BFTE = best-fit toric ellipsoid; Central zone =measurements of 2-mm
zone and center; Max. elevation =measurements of maximal elevation zone
aP value between preoperative and 6-month postoperative corneal elevation values in each group
bP value between changes in preoperative and postoperative corneal elevation values of PRK-CXL and PRK group
Lee et al. BMC Ophthalmology  (2016) 16:139 Page 4 of 9
When analyzing posterior maximum corneal eleva-
tions, the PRK group showed a significant forward
displacement of the posterior corneal surface with the
BFS (P = 0.009). When calculated with the BFTE, the
PRK group showed forward displacement of the pos-
terior corneal surface, although it did not reach statis-
tical significance. The PRK-CXL group showed no
significant change when calculated with the BFS and
showed a significant backward displacement of the
posterior corneal surface when calculated with the
BFTE (P = 0.047; Fig. 1).
In the PRK-CXL group, optical zone diameter (r=−0.314,
P= 0.049) and spherical equivalent (r = −0.369, P = 0.019)
were significantly correlated with the changes in posterior
corneal elevation (BFS) at the maximal elevation zone.
Additionally, a significant correlation was observed
between total ablation zone diameter and changes in
posterior corneal elevation (BFTE) at the peripheral
zone (r = 0.336, P = 0.034). In the PRK group, signifi-
cant correlations were observed between optical zone
diameter and changes in posterior corneal elevation
(BFS) at the maximal elevation zone (r = 0.339, P = 0.028)
Table 3 Comparison of posterior corneal elevation values by fitting the corneal shape to a best-fit sphere or best-fit toric ellipsoid
reference surface between eyes that underwent combined transepithelial photorefractive keratectomy and accelerated corneal
collagen cross-linking and transepithelial photorefractive keratectomy alone
PRK-CXL group (n = 40) PRK group (n = 42) Pb
Pre 6 mon Δ Pa Pre 6 mon Δ Pa
Peripheral zone
Post. elevation (μm, BFS) –4.46 ± 4.37 –3.72 ± 4.58 0.75±1.58 .005 –3.79±4.46 –1.16±4.99 2.63±3.24 <.001 .001
Post. elevation (μm, BFTE) –0.38 ± 4.45 0.12±4.40 0.50±1.35 .024 0.59±4.44 2.61±5.22 2.02±3.43 <.001 .010
Central zone
Post. elevation (μm, BFS) 4.11±5.80 0.23±5.46 –3.88 ± 4.84 <.001 3.30±7.28 –2.52 ± 7.01 –5.82 ± 8.81 <.001 .220
Post. elevation (μm, BFTE) 1.31 ± 6.67 –2.16 ± 5.32 –3.47 ± 4.86 <.001 –1.26±7.33 –8.17 ± 7.59 –6.90 ± 9.90 <.001 .049
Max. elevation
Post. elevation (μm, BFS) 20.28 ± 7.18 20.95 ± 7.80 0.68±5.34 .429 19.5±7.19 22.26 ± 9.64 2.69±6.35 .009 .124
Post. elevation (μm, BFTE) 9.10±3.36 7.78±4.00 –1.33±4.08 .047 9.29±3.93 10.88±3.51 1.60±5.31 .059 .007
PRK-CXL = Combined transepithelial photorefractive keratectomy and accelerated corneal collagen cross-linking; PRK = transepithelial photorefractive keratectomy;
Δ = change; Peripheral zone =measurements of 6-mm and 4-mm zone; BFS = best-fit sphere; BFTE = best-fit toric ellipsoid; Central zone =measurements of 2-mm
zone and center; Max. elevation =measurements of maximal elevation zone
aP value between preoperative and 6-month postoperative corneal elevation values in each group
bP value between changes in preoperative and postoperative corneal elevation values of PRK-CXL and PRK group
Fig. 1 Comparison of changes in preoperative and postoperative corneal elevation values between eyes that underwent combined transepithelial
photorefractive keratectomy and accelerated corneal collagen cross-linking and transepithelial photorefractive keratectomy alone.
PRK-CXL = Combined transepithelial photorefractive keratectomy and accelerated corneal collagen cross-linking; PRK = transepithelial
photorefractive keratectomy; Δ = change; pph = measurements of 6-mm and 4-mm zone; central = measurements of 2-mm zone and
center; max = measurements of maximal elevation zone; BFTE = best-fit toric ellipsoid; BFS = best-fit sphere. Error bars represent
standard error of the mean (*p < 0.05, **p < 0.01)
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as well as between spherical equivalent and changes
in posterior corneal elevation at the peripheral (BFTE:
r = 0.349, P = 0.023; BFS: r = 0.322, P = 0.037) and
maximal elevation (BFS: r = 0.393, P = 0.010) zones. There
were no significant correlations between the changes in
posterior corneal elevation at the peripheral, central, and
maximal elevation zones and ablation depth in the
PRK-CXL or PRK group (Fig. 2).
Upon multivariate linear regression analysis, none of
the preoperative parameters were revealed to be the pri-
mary determinants of changes in posterior corneal eleva-
tion at the peripheral, central, and maximal elevation
zones in either group.
Discussion
In the present study, we investigated the changes in ele-
vation of the anterior and posterior corneal surfaces
after combined transepithelial PRK and accelerated
corneal CXL and after transepithelial PRK alone. We
demonstrated that combined transepithelial PRK and
CXL induces significant elevation of the peripheral pos-
terior corneal surface, but compared with transepithelial
PRK alone, combined procedures show significant small
amount of forward displacement of the peripheral pos-
terior corneal surface. Furthermore, when analyzing
posterior maximum corneal elevations, we found that
combined procedures induce significant backward dis-
placement of the posterior corneal surface.
Previous studies have reported forward displacement
of the posterior corneal surface after myopic laser re-
fractive surgery using scanning-slit topography and
Scheimpflug tomography [1–5]. A recent study evaluat-
ing the change in posterior corneal elevation using
swept-source optical coherence tomography after PRK
described significant forward protrusion of the posterior
corneal surface above BFS (8.0-mm-diameter), although
Fig. 2 Correlations between changes in posterior corneal elevation values and ablation depth in eyes that underwent combined transepithelial
photorefractive keratectomy and accelerated corneal collagen cross-linking and transepithelial photorefractive keratectomy alone. (a) PRK-CXL group,
(b) PRK group. PRK-CXL = Combined transepithelial photorefractive keratectomy and accelerated corneal collagen cross-linking; PRK = transepithelial
photorefractive keratectomy; Δ = change; Peripheral zone =measurements of 6-mm and 4-mm zone; BFTE = best-fit toric ellipsoid; BFS = best-fit
sphere; Central zone =measurements of 2-mm zone and center; max. elevation =measurements of maximal elevation zone
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magnitude was small (<4 μm) [22]. Detecting changes in
the posterior corneal elevation after myopic laser refract-
ive surgery is crucial because such changes are linked to
postoperative keratectasia, a serious complication of re-
fractive corneal surgery. The Scheimpflug tomography
system used in this study enables measurements of
changes in the posterior corneal elevation from the pos-
terior corneal surface directly by elevation-based system.
In the present study, we hypothesized that application
of prophylactic CXL while performing a laser ablation
procedure could have a positive effect on regression of
refractive effects and the forward or backward placement
of the posterior corneal surface. We developed our hy-
pothesis on the basis of recently published articles de-
scribing prophylactic CXL performed simultaneously
with myopic LASIK surgery [17, 19]. The development
of combined LASIK and CXL is based upon findings
that myopia correction with LASIK in highly myopic
eyes has shown a tendency to produce corneal steepen-
ing during long-term follow-up, consequently resulting
in myopic shift. [23] Combined LASIK and CXL is
thought to strengthen the cornea, especially in highly
myopic eyes with thin residual stroma. Furthermore,
clinical studies of the effects of combined LASIK and
CXL in highly myopic eyes have demonstrated improved
refractive and keratometric stability [19, 24, 25].
We analyzed posterior corneal elevations using eleva-
tion maps provided by Scheimpflug tomography. The
Scheimpflug camera software calculates corneal eleva-
tion values by fitting a reference surface body, either a
sphere (best-fit sphere; BFS) or an ellipsoid (best-fit toric
ellipsoid; BFTE), to the corneal shape [26]. Previous
studies have demonstrated the results of elevation data
by fitting a sphere to the corneal shape, using the BFS as
reference surface. In our study, however, in an attempt
to improve the accuracy of posterior elevation measure-
ments, we used the BFTE (8.0 mm in diameter) with a
fixed eccentricity of 0.4 as the reference surface. Because
the cornea is normally aspheric and ellipsoid, a toric el-
lipsoid approximates the actual shape of the normal cor-
nea, thus demonstrating local elevation changes with
more sensitivity than does the BFS [27, 28]. Sideroudi et
al. reported that the results of posterior corneal eleva-
tions above the BFTE provide elevation measurements
with the highest diagnostic capacity in suspected ectatic
corneas [29].
Both groups in our study demonstrated peripheral an-
terior corneal elevations along with backward displace-
ment of the central anterior corneal surface, regardless
of the calculation method (BFS or BFTE). In cases with
posterior corneal elevations, transepithelial PRK alone
induced a significant forward displacement of the per-
ipheral posterior corneal surface and a simultaneous
backward displacement of the central posterior corneal
surface. This finding is consistent with that of a previous
publication that suggested a conceptual model for bio-
mechanical central flattening as a direct consequence of
severed corneal lamellae after myopic laser refractive
surgery [30]. According to this theory, central lamellae
are severed after surgery and are obliterated centrally;
the remaining peripheral lamellae relax, and interlamel-
lar distances expand with the reduction of lamellar ten-
sion [30]. This process allows the peripheral cornea to
thicken, and ultimately an outward radial force in the
peripheral cornea pulls laterally on the center and flat-
tens the central cornea.
In line with changes induced by transepithelial PRK
alone, combined transepithelial PRK and accelerated
CXL induced a forward displacement of the peripheral
posterior corneal surface and backward displacement of
the central posterior corneal surface. However, the mag-
nitudes of the changes were significantly smaller in com-
bined transepithelial PRK and accelerated CXL than in
transepithelial PRK alone when the BFTE was used as
the reference surface. Furthermore, an analysis of poster-
ior maximum corneal elevations demonstrated that
combined transepithelial PRK and accelerated CXL in-
duced a significant backward displacement of the poster-
ior corneal surface.
We believe that because a prophylactic CXL interven-
tion strengthens the corneal tissue, an outward radial ex-
pansion force in the periphery may cause little pull on
the underlying intact corneal tissue. Accordingly, we
found peripheral posterior corneal elevation and central
corneal flattening that were small in magnitude in the
combined PRK and accelerated CXL group. Additionally,
backward displacement of the posterior corneal surface
at maximum corneal elevations is expected to be attrib-
uted to the presence of a prophylactic CXL intervention.
CXL can provide biomechanical stability through
corneal stiffening by causing formation of additional
covalent connections between collagen fibers that conse-
quently stabilize stromal collagen fibers and harden the
structure of the collagen [11, 12]. In one study evaluat-
ing the effect of CXL on ectasia after excimer laser
refractive surgery, keratocyte nuclei apoptosis in the an-
terior and intermediate corneal stroma caused signifi-
cant tissue alteration during the first 3 months [31].
Stromal edema accompanied by keratocyte loss persists
for 4 to 6 weeks and then gradually resolves with kerato-
cyte repopulation and stromal collagen accumulation
[32, 33]. Compared with conventional CXL, accelerated
CXL is associated with a greater extent of keratocyte
and corneal nerve apoptosis during the first 3 months
following CXL [34, 35]. Based upon aforementioned
changes in keratocyte apoptosis or repopulation, our fu-
ture research will focus on investigating the relationship
between posterior corneal elevations and changes in
Lee et al. BMC Ophthalmology  (2016) 16:139 Page 7 of 9
keratocyte nuclei after combined PRK and CXL during a
longer follow-up period.
The present study had several limitations, including its
retrospective design and relatively short period of obser-
vation. Another limitation is that we included two or
one eyes in each patient. Additionally, this was not a
randomized comparative study of contralateral eyes. In
the present study, CCT of the PRK-CXL group was
lower than that of the PRK group. Given that thinner
corneas are prone to deformation, our results should be
interpreted with caution. To validate our results, we
intend to perform further prospective, randomized,
contralateral paired-eye, clinical trials evaluating the ef-
fects of PRK with or without accelerated corneal CXL
alone on posterior corneal elevations.
Conclusions
A forward displacement of the peripheral posterior cor-
neal surface was induced in both groups, along with a
backward displacement of the central posterior corneal
surface, regardless of the calculation method. Most not-
ably, transepithelial PRK combined with a prophylactic
CXL intervention significantly reduced the magnitudes
of displacement of the peripheral and central posterior
corneal surfaces, accompanied by the backward displace-
ment of the posterior corneal surface at maximum
corneal elevations when the BFTE was used as the refer-
ence surface.
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